RxDoctor Payments Data

Kristi Steinert, PA

Physician Assistant · Enid, OKNPI 1346213915

Payments from drug & device makers

$5,808in general payments, 2019–2025

Across 325 payments — averaging $17.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$977
  • LEO Pharma Inc.$652
  • Sanofi$465
  • Lilly USA, LLC$455
  • Novartis$435
  • E.r. Squibb & Sons, L.L.C.$349
  • plus $2K from 21 others

What the payments were for

  • Food & beverage$5,58396%
  • Education$2244%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,808 in reported general payments places this provider in the 90th percentile of 1,491 physician assistant providers in Oklahoma.

See all physician assistant providers in Oklahoma

Medicare billing

Part B allowed, 2024
$306,855
Medicare patients
1,458
Services billed
6,777

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Skyrizi PenRisankizumab-Rzaa19$388,654
Dupixent PenDupilumab21$80,225
Cosentyx Sensoready (2 Pens)Secukinumab11$79,732
Fluorouracil119$7,816
Ketoconazole262$5,489
Clobetasol Propionate89$4,667
Doxycycline Hyclate207$4,147
Clindamycin Phosphate80$2,309
Tacrolimus14$2,109
Fluocinonide40$1,715
Metronidazole22$1,466
Tretinoin22$1,444
Mupirocin143$1,079
Triamcinolone Acetonide87$767
Hydrocortisone51$735

Paid to pharmacies, not to this prescriber.

Other physician assistant in Enid

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →